Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Overview

Journal Nutrients

Date 2023 May 27

PMID 37242277

Authors

Ling Pan

Jing Sui

Ying Xu

Qun Zhao

Affiliations

Soon will be listed here.

Abstract

Although previous epidemiological studies have been conducted to investigate the relationship between nut consumption and the risk of nonalcoholic fatty liver disease (NAFLD), the evidence remains inconclusive and contentious. The aim of our study was to further conduct a meta-analysis of observational studies to explore the latest evidence of the influence of nut consumption on NAFLD. This meta-analysis included a comprehensive search of all articles published in the PubMed and Web of Science online databases as of April 2023. A total of 11 articles were included, comprising 2 prospective cohort studies, 3 cross-sectional studies, and 7 case-control studies, and a random effects model was used to evaluate the relationship between nuts and NAFLD. Results showed that the odds ratio (OR) of NAFLD was 0.90 (95% CI: 0.81-0.99, < 0.001) when comparing the highest and lowest total nut intake, indicating a significant negative correlation. Furthermore, subgroup analysis revealed that the protective effect of nuts on NAFLD was more significant in females (OR = 0.88; 95% CI: 0.78-0.98, = 76.2%). In summary, our findings provide support for a protective relationship between nut intake and risk of NAFLD. Further exploration of the association between other dietary components and NAFLD is an important avenue for future research.

Citing Articles

The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease.

Mackow M, Dziubyna T, Jamer T, Slivinskyi D, Pytrus T, Neubauer K Nutrients. 2024; 16(20).

PMID: 39458499 PMC: 11510335. DOI: 10.3390/nu16203505.

The effects of time-restricted eating for patients with nonalcoholic fatty liver disease: a systematic review.

Lin X, Wang S, Huang J Front Nutr. 2024; 10:1307736.

PMID: 38239843 PMC: 10794638. DOI: 10.3389/fnut.2023.1307736.

References

Tindall A, Petersen K, Lamendella R, Shearer G, Murray-Kolb L, Proctor D . Tree Nut Consumption and Adipose Tissue Mass: Mechanisms of Action. Curr Dev Nutr. 2018; 2(11):nzy069. PMC: 6252345. DOI: 10.1093/cdn/nzy069. View

Chu Y, Yang H, Wu H, Liu J, Wang L, Lu S . Aflatoxin B exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. Int J Cancer. 2017; 141(4):711-720. PMC: 5513813. DOI: 10.1002/ijc.30782. View

Quesada-Vazquez S, Aragones G, Bas J, Escote X . Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. Cells. 2020; 9(1). PMC: 7016763. DOI: 10.3390/cells9010176. View

Theodore L, Kellow N, McNeil E, Close E, Coad E, Cardoso B . Nut Consumption for Cognitive Performance: A Systematic Review. Adv Nutr. 2020; 12(3):777-792. PMC: 8166568. DOI: 10.1093/advances/nmaa153. View

Van Name M, Savoye M, Chick J, Galuppo B, Feldstein A, Pierpont B . A Low ω-6 to ω-3 PUFA Ratio (n-6:n-3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth. J Nutr. 2020; 150(9):2314-2321. PMC: 7467848. DOI: 10.1093/jn/nxaa183. View

Dos Santos J, Schaan de Quadros A, Weschenfelder C, Garofallo S, Marcadenti A . Oxidative Stress Biomarkers, Nut-Related Antioxidants, and Cardiovascular Disease. Nutrients. 2020; 12(3). PMC: 7146201. DOI: 10.3390/nu12030682. View

Belardo D, Michos E, Blankstein R, Blumenthal R, Ferdinand K, Hall K . Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement. Am J Prev Cardiol. 2022; 10:100323. PMC: 8914096. DOI: 10.1016/j.ajpc.2022.100323. View

Ventriglio A, Sancassiani F, Contu M, Latorre M, Di Salvatore M, Fornaro M . Mediterranean Diet and its Benefits on Health and Mental Health: A Literature Review. Clin Pract Epidemiol Ment Health. 2020; 16(Suppl-1):156-164. PMC: 7536728. DOI: 10.2174/1745017902016010156. View

Asbaghi O, Emamat H, Rezaei Kelishadi M, Hekmatdoost A . The Association between Nuts Intake and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: a Case-Control Study. Clin Nutr Res. 2020; 9(3):195-204. PMC: 7402977. DOI: 10.7762/cnr.2020.9.3.195. View

10.

Spence D, Stewart W . Proline inhibits N2-fixation in Anabaena 7120. Biochem Biophys Res Commun. 1986; 139(3):940-6. DOI: 10.1016/s0006-291x(86)80268-6. View

11.

Maestri M, Santopaolo F, Pompili M, Gasbarrini A, Ponziani F . Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies. Front Nutr. 2023; 10:1110536. PMC: 9978194. DOI: 10.3389/fnut.2023.1110536. View

12.

Raza S, Rajak S, Upadhyay A, Tewari A, Sinha R . Current treatment paradigms and emerging therapies for NAFLD/NASH. Front Biosci (Landmark Ed). 2020; 26(2):206-237. PMC: 7116261. DOI: 10.2741/4892. View

13.

Wernicke C, Pohrt A, Pletsch-Borba L, Apostolopoulou K, Hornemann S, Meyer N . Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial. Am J Clin Nutr. 2023; 117(4):785-793. DOI: 10.1016/j.ajcnut.2023.01.010. View

14.

Cardoso B, Tan S, Daly R, Dalla Via J, Georgousopoulou E, George E . Intake of Nuts and Seeds Is Associated with a Lower Prevalence of Nonalcoholic Fatty Liver Disease in US Adults: Findings from 2005-2018 NHANES. J Nutr. 2021; 151(11):3507-3515. DOI: 10.1093/jn/nxab253. View

15.

Nagashimada M, Ota T . Role of vitamin E in nonalcoholic fatty liver disease. IUBMB Life. 2018; 71(4):516-522. DOI: 10.1002/iub.1991. View

16.

Eslami O, Khorramrouz F, Sohouli M, Bagheri N, Shidfar F, Fernandez M . Effect of nuts on components of metabolic syndrome in healthy adults with overweight/obesity: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022; 32(11):2459-2469. DOI: 10.1016/j.numecd.2022.07.015. View

17.

Gupta V, Mah X, Garcia M, Antonypillai C, van der Poorten D . Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World J Gastroenterol. 2015; 21(37):10621-35. PMC: 4588084. DOI: 10.3748/wjg.v21.i37.10621. View

18.

Marin-Alejandre B, Abete I, Cantero I, Monreal J, Elorz M, Herrero J . The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial. Nutrients. 2019; 11(10). PMC: 6836315. DOI: 10.3390/nu11102543. View

19.

Vadivel V, Kunyanga C, Biesalski H . Health benefits of nut consumption with special reference to body weight control. Nutrition. 2012; 28(11-12):1089-97. DOI: 10.1016/j.nut.2012.01.004. View

20.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View